Barchart Demo Center



Stock Screeners




Fund Screeners

Foreign Exchange



Financial Calculators

Embedded Widgets



JSON Feeds

Symbol Overview

United States|Canada

Sesen Bio Inc

Add to Portfolio
-0.0110 (-2.08%)
as of Apr 3, 2020

Sesen Bio Announces Changes to the Board of Directors

BusinessWire via COMTEX - Mon Feb 24, 04:30PM EST
Sesen Bio (Nasdaq: SESN) a late-stage clinical company developing targeted fusion protein therapeutics for the treatment of patients with cancer, today announced the appointment of Carrie Bourdow, chief executive officer of Treven(full story)
TRVN: 0.4750 (-0.0280), SESN: 0.5190 (-0.0110)

Growing Global Demand for Non-Invasive Cellulite

PR Newswire via COMTEX - Wed May 29, 08:50AM EDT
Cellulite affects 85% to 90% of all women worldwide and was first described nearly 100 years ago, and has been the bane of women (and men) ever since. But to find a 'cure' or effective 'solution' the cause must be understood. Firs(full story)
SOLY: 7.10 (-0.16), BSX: 31.17 (+0.12), SWAV: 29.49 (+0.44), SESN: 0.5190 (-0.0110), PFE: 33.64 (+0.77)

Positive Results and New Technology Give Rise to

GlobeNewswire via COMTEX - Wed Mar 27, 08:00AM EDT, a leading investor news resource covering biotech and pharma stocks releases a snapshot looking at the biopharmaceutical market and how monoclonal antibody research is gaining market dominance.(full story)
IPA.VN: 0.800 (+0.010), IPATF: 0.5710 (+0.0110), ZYME: 33.67 (-0.66), ZYME.TO: 33.10 (+0.53), SESN: 0.5190 (-0.0110), PMN.TO: 0.13 (unch), ARFXF: 0.0920 (+0.0020)

Demand for Cancer Treatment Remains High Despite

PR Newswire via COMTEX - Wed Feb 13, 09:00AM EST
Deaths related to cancer dropped by 27% in the past quarter-century, meaning that 2.6 million fewer people died due to cancer during that time period, according to a report by the American Cancer Society. Researchers noted that fo(full story)
SNETD: 0.3900 (+0.0500), SNET: 0.0103 (+0.0040), SESN: 0.5190 (-0.0110), CGIX: 3.16 (+0.75), ABIO: 2.84 (+0.02), NAVB: 0.7673 (-0.0129)